CRDF R&D Expenses
Cardiff Oncology Inc · R&D Expenses
CRDF R&D Expenses
Latest reported$25.95Mperiod ending
CRDF TTM R&D Expenses ($1.55M → $25.95M)
TTM R&D Expenses
High-resolution chart · PNG
CRDF r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 25,952,000 | |
| 31,617,000 | |
| 35,329,000 | |
| 39,966,000 | |
| 41,409,000 | |
| 39,322,000 | |
| 36,853,000 | |
| 34,904,000 | |
| 33,286,000 | |
| 31,813,000 | |
| 32,857,000 | |
| 31,536,000 | |
| 29,523,000 | |
| 28,951,000 | |
| 27,107,000 | |
| 26,489,000 | |
| 24,634,000 | |
| 21,305,000 | |
| 17,376,000 | |
| 14,751,171 | |
| 13,452,171 | |
| 11,809,171 | |
| 11,236,171 | |
| 10,901,473 | |
| 10,865,297 | |
| 11,219,297 | |
| 11,162,297 | |
| 10,794,824 | |
| 9,806,441 | |
| 8,929,208 | |
| 8,164,046 | |
| 6,874,046 | |
| 6,458,311 | |
| 5,487,259 | |
| 7,883,251 | |
| 10,461,251 | |
| 12,983,943 | |
| 16,078,642 | |
| 15,006,876 | |
| 14,387,876 | |
| 12,997,011 | |
| 11,604,597 | |
| 10,594,192 | |
| 9,263,192 | |
| 8,706,910 | |
| 7,420,083 | |
| 6,664,945 | |
| 6,115,983 | |
| 5,041,189 | |
| 4,587,865 | |
| 3,947,589 | |
| 3,255,551 | |
| 2,851,527 | |
| 2,384,829 | |
| 1,919,991 | |
| 1,634,448 | |
| 1,323,939 | |
| 990,076 | |
| 910,685 | |
| 182,228 | |
| -18,696 | |
| 68,016 | |
| 0 | |
| 420,000 | |
| 420,000 | |
| 190,000 | |
| 366,555 | |
| 632,716 | |
| 929,362 | |
| 1,548,997 | |
| 1,182,442 | |
| 916,281 | |
| 619,635 |